Will pCR and Pembro Redefine Breast Cancer Treatment?

Dr Laura Esserman discusses the ground-breaking I-SPY breast cancer research platform and its most ' exciting ' results to date, indicating that pembrolizumab triples pCR in TNBC.

Source: Medscape Oncology - June 19, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts